Your GLP-1 pharma marketing strategy should be omnichannel yet intentional, leveraging the right tools for each stakeholder group
Sirt3 also aids in the deacetylation of YME1L, inhibiting its degradation activity and reducing the accumulation of S-OPA1, thereby promoting mitochondrial fusion through an alternative pathway [85]
Several potential health conditions may benefit from an increased intake of L-arginine
SUSTAIN-6, which showed cardiovascular safety for semaglutide, also had a flozin-like 26% reduction in CV death, heart attack, or stroke (Figure 7)
GLP-1 medications delay gastric or stomach emptying, which slows digestion
Most recently, we added Efimosfermin Alfa for Nonalcoholic Steatohepatitis, Efimosfermin Alfa for NASH and Tirzepatide + Retatrutide for Fatty Liver Disease to the Power online platform.